$4.58
-0.93-16.97%
Last update: Oct 9, 8:00 PM
$6.11
0.6010.89%
Apimeds Pharmaceuticals Us Inc (APUS) Stock Price, Quote, News & History
APUSAMEX
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Apimeds Pharmaceuticals (AMEX:APUS) through any online brokerage.
Other companies in Apimeds Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
There is no analysis for Apimeds Pharmaceuticals to provide a consensus price target.
The stock price for Apimeds Pharmaceuticals (AMEX: APUS) is $6.11 last updated October 9, 2026 at 8:00 PM EDT.
There are no upcoming dividends for Apimeds Pharmaceuticals.
Apimeds Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Apimeds Pharmaceuticals.
Apimeds Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being...
